Detection of renal allograft rejection by complement components C5A and TCC in plasma and urine

Journal of Laboratory and Clinical Medicine

Volumn 129, Issue 1, 1997, Pages 62-71

  Müller, Thomas F ^a   Kraus, Michael ^a   Neumann, Christine ^a   Lange, Harald ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030723790     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90162-1     Document Type: Article

References (33)

1. Couser WG, Baker PJ, Adler S. Complement and the direct mediation of immune glomerular injury: a new perspective. Kidney Int 1985;28:879-90.
2. Andrews PA, Zhou W, Sacks SH. Tissue synthesis of complement as an immune regulator. Mol Med Today 1995;2: 202-7.
3. Biesecker G, Katz S, Koffler D. Renal localization of the membrane attack complex in systemic lupus erythematosus nephritis. J Exp Med 1981;154:1779-94.
4. Cosyns JP, Kazatchkine MD, Bhakdi S, Mandet C, Grossetete J, Hinglais N, et al. Immunohistochemical analysis of C3 cleavage fragments, factor H, and the C5b-9 terminal complex of complement in de novo membranous glomerulonephritis occurring in patients with renal transplant. Clin Nephrol 1986;26:203-8.
5. Falk RJ, Dalmasso AP, Kim Y, Tsai CH, Scheinman JI, Gewurz H, et al. Neoantigen of the polymerized nineth component of complement. J Clin Invest 1983;72:560-73.
6. Feucht HE, Felber E, Gokel MJ, Hillebrand G, Natterman U, Brockmeyer C, et al. Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol 1991;86:464-70.
7. Baker PJ, Ochi RF, Schulze M, Johnson RJ, Campbell C, Couser WG. Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats. Am J Pathol 1989;135:185-94.
8. Perrin LH, Lambert PH, Miescher PA. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis. J Clin Invest 1975;56:165-76.
9. Matsell DG, Ill SR, Tamerius JD, Marrow PR, Kolb WP, Wyatt RJ. Plasma terminal complement complexes in acute poststreptococcal glomerulonephritis. Am J Kidney Dis 1991; 17:311-6.
10. Kirschfink M, Wienert T, Rother K, Pomer S. Complement activation in renal allograft recipients. Transpl Proc 1992;24: 2556-7.
11. Krediet RT, Asghar SS, Koomen GCM, Venneker GT, Struijk DG, Arisz L. Effects of renal failure on complement C3d levels. Nephron 1991;59:41-5.
12. Platt JL, Bach FH. The barrier to xenotransplantation. Transplantation 1991;52:937-47.
13. Levine PH, Merrill DA, Kohler PF, Claman HN. Changes in serum immunoglobulin and complement levels following renal homotransplantation. Transplantation 1970;10:141-54.
14. Carpenter CB. Abnormalities of the complement system in clinical transplantation situations. Transpl Proc 1974;6:83-7.
15. Shabtai M, Waltzer WC, Miller F, Anaise D, Rapaport FT. Specificity of immune complex/complement deposits in the mediation of immunologic injury to renal allografts. Transpl Proc 1989;21:278-9.
16. Bechtel U, Scheuer R, Landgraf R, König A, Feucht HE. Assessment of soluble adhesion molecules (sICAM-1, sVCAM-1, sELAM-1) and complement cleavage products (sC4d, sC5b-9) in urine. Clinical monitoring of renal recipients. Transplantation 1995;58:905-11.
17. Carpenter CB. The early diagnosis of renal allograft rejection in man. Advances in nephrology from the Necker Hospital (Chicago). 1975;5:229-56.
18. Müller MM, Andert SE, Winter PM, Holzinger CH. Laboratory diagnostics in organ transplantation. Lab Med 1990; 14:51-62.
19. Müller T, Schindler S, Sprenger H, Steinmetz A, Hocke G, Ebel H, et al. Prospective analysis of 10 different parameters of acute renal allograft rejection. Trans Proc 1992;24:2731-34.
20. Soiling J. Circulating immune complexes and complement breakdown product C3d in gomerulonephritis and in kidney transplantation. Acta Path Microbiol Immunol Scand Sect C 1984;92:213-20.
21. Klos A, Ihrig V, Messner M, Grabbe J, Bitter-Suermann D. Detection of native human complement components C3 and C5 and their primary activation peptides C3a and C5a (anaphylatoxic peptides) by ELISAs with monoclonal antibodies. J Immunol Meth 1988;111:241-52.
22. Mollnes TE, Lea T, Harboie M, Tschopp J. Monoclonal antibodies recognizing a neoantigen of poly (C9) detect the human terminal complement complex in tissue and plasma. Scand J Immunol 1985;22:183-95.
23. Kraus M, Becker U, Aillaud E. Enzyme immunoassay for determination of human SC5b-9 complement complex (abstract). Compl Inflamm 1991;8:177-8.
24. Büttner J. Evaluation of the diagnostic value of clinical chemical tests. J Clin Chem Clin Biochem 1977;15:1-12.
25. Poses RM, Cebul RD, Centor RM. Evaluating physicians' probabilistic judgements. Med Decis Making 1988;8:233-40.
26. Schulze M, Donadio JV, Pruchno CJ, Baker PJ, Johnson RJ, Stahl RAK, et al. Elevated urinary excretion of the C5b-9 complex in membranous nephropathy. Kidney Int 1991;40: 522-8.
27. Zhow XJ, Niesen N, Pawlowski I, Biesecker G, Andres G, Brentjens J, et al. Prolongation of survival of discordant kidney xenografts by C6 deficiency. Transplantation 1990;50: 896-8.
28. Feucht HE, Schneeberger J, Hillebrand G, Burkhardt K, Weiss M, Riethmüller G, et al. Capillary deposition of C4d complement fragment and early graft loss. Kidney Int 1993; 43:1333-8.
29. Andrews PA, Finn JE, Lloyd CM, Zhou W, Mathieson PW, Sacks SH. Expression and tissue localization of donor-specific complement C3 synthesized in human renal allografts. Eur J Immunol 1995;25:1087-93.
30. van Son WJ, van der Bij W, Tegzess AM, Anema J, van der Giessen M, van der Hem GK, et al. Complement activation during an active cytomegalovirus infection after renal transplantation: due to circulating immune complexes or alternative pathway activation? Clin Immunol Immunopathol 1989; 50:109-21.
31. Mollnes TE, Lachmann PJ. Regulation of complement. Scand J Immunol 1988;27:127-42.
32. Pruchno CJ, Burns MM, Schulze M, Johnson RJ, Baker PJ, Alpers CE, et al. Urinary excretion of the C5b-9 membrane attack complex of complement is a marker of immune disease activity in autologous immune complex nephritis. Am J Pathol 1991;138:203-11.
33. Seelen MAJ, Brooimans RA, van der Woude FJ, van Es LA, Daha MR. IFN-γ mediates stimulation of complement C4 biosynthesis in human proximal tubular epithelial cells. Kidney Int 1993;44:50-7.